Pfizer applies for full FDA approval of its COVID-19 vaccine

Pfizer and BioNTech announced this morning that they have applied for full approval with the U.S. Food and Drug Administration for their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in New York City

Hometown Heroes in the Hudson Valley

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Hometown Heroes in Connecticut

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines